Total Payments
$3,320
2024 Payments
$544.49
Companies
28
Transactions
204
Medicare Patients
2,051
Medicare Billing
$161,809
Payment Breakdown by Category
Food & Beverage$3,123 (94.1%)
Education$196.55 (5.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,123 | 200 | 94.1% |
| Education | $196.55 | 4 | 5.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $693.15 | 45 | $0 (2024) |
| Amgen Inc. | $366.04 | 27 | $0 (2024) |
| Astellas Pharma US Inc | $347.37 | 14 | $0 (2022) |
| GlaxoSmithKline, LLC. | $324.67 | 20 | $0 (2024) |
| Novo Nordisk Inc | $269.97 | 18 | $0 (2024) |
| PFIZER INC. | $201.72 | 11 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $155.76 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $140.20 | 9 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $89.94 | 6 | $0 (2019) |
| Exact Sciences Corporation | $89.13 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $544.49 | 32 | Lilly USA, LLC ($203.97) |
| 2023 | $764.37 | 52 | Lilly USA, LLC ($225.69) |
| 2022 | $451.65 | 29 | Amgen Inc. ($98.63) |
| 2021 | $332.33 | 13 | Astellas Pharma US Inc ($94.95) |
| 2020 | $14.21 | 1 | Radius Health, Inc. ($14.21) |
| 2019 | $159.17 | 12 | Astellas Pharma US Inc ($51.41) |
| 2018 | $195.84 | 14 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($40.18) |
| 2017 | $857.75 | 51 | Astellas Pharma US Inc ($176.50) |
All Payment Transactions
204 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: Oncology | ||||||
| 08/13/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: Diabetes | ||||||
| 07/15/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Diabetes | ||||||
| 06/29/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $2.14 | General |
| Category: Diabetes | ||||||
| 06/28/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 06/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Cardiology | ||||||
| 05/22/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Inflammation | ||||||
| 05/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: UROLOGY | ||||||
| 05/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.13 | General |
| Category: Diabetes | ||||||
| 05/13/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: RESPIRATORY | ||||||
| 05/10/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: VACCINES | ||||||
| 05/02/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: Diabetes | ||||||
| 04/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.58 | General |
| Category: PSYCHIATRY | ||||||
| 04/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: Diabetes | ||||||
| 04/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Diabetes | ||||||
| 04/01/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $31.29 | General |
| Category: RESPIRATORY | ||||||
| 03/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Inflammation | ||||||
| 03/06/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Respiratory | ||||||
| 03/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Diabetes | ||||||
| 03/05/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $0.72 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 378 | 479 | $84,946 | $38,768 |
| 2022 | 13 | 650 | 742 | $106,533 | $51,506 |
| 2021 | 14 | 504 | 587 | $84,575 | $38,441 |
| 2020 | 11 | 519 | 647 | $79,927 | $33,094 |
Total Patients
2,051
Total Services
2,455
Medicare Billing
$161,809
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 206 | $45,359 | $16,959 | 37.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 78 | 78 | $17,592 | $9,639 | 54.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 17 | 17 | $7,220 | $4,785 | 66.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 41 | 41 | $5,075 | $3,108 | 61.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 26 | 31 | $4,948 | $2,013 | 40.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $2,795 | $1,269 | 45.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 15 | 15 | $951.00 | $442.65 | 46.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 17 | 17 | $531.00 | $299.03 | 56.3% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 12 | 12 | $380.00 | $211.08 | 55.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 15 | 19 | $95.00 | $41.80 | 44.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 123 | 211 | $46,764 | $18,164 | 38.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 107 | 107 | $24,393 | $13,563 | 55.6% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 26 | 26 | $11,025 | $7,255 | 65.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 48 | 48 | $5,713 | $3,372 | 59.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 104 | 104 | $3,224 | $1,851 | 57.4% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 13 | 13 | $2,760 | $1,723 | 62.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 52 | 53 | $3,241 | $1,504 | 46.4% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 80 | 80 | $2,480 | $1,450 | 58.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 25 | 25 | $3,955 | $1,344 | 34.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 34 | 34 | $2,078 | $970.14 | 46.7% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 13 | $496.00 | $143.36 | 28.9% |
| 90471 | Administration of vaccine | Office | 2022 | 11 | 11 | $319.00 | $129.82 | 40.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 17 | $85.00 | $37.61 | 44.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 95 | 136 | $30,249 | $12,512 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 76 | 76 | $17,085 | $9,801 | 57.4% |
About Dr. Yvette Alvarez, D.O
Dr. Yvette Alvarez, D.O is a Family Medicine healthcare provider based in Rockport, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1528328309.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yvette Alvarez, D.O has received a total of $3,320 in payments from pharmaceutical and medical device companies, with $544.49 received in 2024. These payments were reported across 204 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,123).
As a Medicare-enrolled provider, Alvarez has provided services to 2,051 Medicare beneficiaries, totaling 2,455 services with total Medicare billing of $161,809. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Rockport, TX
- Active Since 05/25/2012
- Last Updated 12/13/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1528328309
Products in Payments
- MOUNJARO (Drug) $464.35
- Otezla (Drug) $241.98
- TRELEGY ELLIPTA (Drug) $190.16
- TRULICITY (Drug) $169.27
- TOUJEO (Drug) $127.84
- Victoza (Drug) $115.52
- Myrbetriq (Drug) $113.45
- GEMTESA (Drug) $104.00
- Ozempic (Drug) $90.71
- Cologuard Collection Kit (Device) $89.13
- AREXVY (Drug) $78.13
- BREZTRI (Drug) $75.55
- PREVNAR 20 (Biological) $68.54
- MYRBETRIQ (Drug) $63.98
- NEXLETOL (Drug) $59.52
- JARDIANCE (Drug) $57.10
- PREVNAR 13 (Biological) $54.17
- Vascepa (Drug) $52.90
- XIFAXAN (Drug) $52.46
- Omnia (Device) $51.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Rockport
Rimantas Kazakevicius, Md, MD
Family Medicine — Payments: $5,849
Family Medicine $5,849
Susan Martin, Md, MD
Family Medicine — Payments: $5,045
Family Medicine $5,045
Mario Perez, D.o, D.O
Family Medicine — Payments: $4,781
Family Medicine $4,781
Dr. Michael Higginbotham, Md, MD
Family Medicine — Payments: $4,760
Family Medicine $4,760
Dr. Katrina Erickson, M.d, M.D
Family Medicine — Payments: $3,134
Family Medicine $3,134
John Root, Md, MD
Family Medicine — Payments: $1,013
Family Medicine $1,013